NEW DELHI, Feb 5: The Centre has placed a purchase order with Biological E for five crore doses of COVID vaccine Corbevax each costing Rs 145 excluding taxes, official sources said on Saturday.
The government is yet to decide on which segment of beneficiaries this new vaccine would be administered.
However, according to sources, discussions are underway in technical groups and in the Health Ministry’s immunisation division about expanding the scope of the precaution doses which are currently being given to healthcare and frontline workers, and co-morbid senior citizens.
The HLL Lifecare Limited, a public sector undertaking, has issued the supply order of Corbevax to Biological E in January-end on behalf of the Union Health Ministry.
According to the order, the Hyderabad-based company is expected to provide the supplies in February. “The cost implication of five crore doses of Corbevax at the rate of Rs 145 per dose plus GST as applicable come to Rs 725 plus GST as applicable.
The government has told Parliament that any decision on expanding the list of eligible beneficiaries for precaution dose of COVID-19 vaccines and vaccination of children below 15 years will be in accordance with the recommendations of the India’s National Technical Advisory Group on Immunisation (NTAGI) based on a review of the available scientific evidence.
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees Celsius to 8 degrees Celsius. It is presented as 0.5 ml (single dose) and 5 ml (10 doses) vial pack. (PTI)
